RYAN BEDNAR: Open Payments
NPI 1376015594 · MEDINA, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,105 in 89 payments from 13 companies in 2025. Trend: 2023 $716 · 2024 $857 · 2025 $1,105
Food & beverage: $1,105
| Company | Payments | Amount |
|---|---|---|
| Lundbeck LLC | 31 | $262 |
| Vanda Pharmaceuticals Inc. | 10 | $167 |
| Otsuka America Pharmaceutical, Inc. | 18 | $139 |
| ABBVIE INC. | 4 | $84 |
| Teva Pharmaceuticals USA, Inc. | 5 | $78 |
| Neurocrine BioSciences, Inc. | 4 | $74 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $68 |
| Axsome Therapeutics, Inc. | 3 | $62 |
| Alkermes, Inc. | 3 | $55 |
| Janssen Pharmaceuticals, Inc | 3 | $53 |
Products named: REXULTI, ABILIFY MAINTENA, FANAPT, VRAYLAR, INGREZZA, CAPLYTA, AUSTEDO XR, Auvelity.
Industry payments across OH — which companies pay providers there.
